BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 17076717)

  • 21. Longitudinal melanonychia associated with fluconazole therapy.
    Kar HK
    Int J Dermatol; 1998 Sep; 37(9):719-20. PubMed ID: 9762834
    [No Abstract]   [Full Text] [Related]  

  • 22. Nail pigmentation due to hydroxycarbamide.
    Ceulen RP; Frank J; Poblete-Gutiérrez P
    Int J Dermatol; 2007 Nov; 46 Suppl 3():13-5. PubMed ID: 17973880
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Inflammatory livedo and idiopathic thrombocythemia. Remarkable therapeutic action of hydroxyurea].
    Lèques B; Texier L; Verdaguer J
    Bull Soc Fr Dermatol Syphiligr; 1967; 74(4):545-8. PubMed ID: 5585217
    [No Abstract]   [Full Text] [Related]  

  • 24. Nail pigmentation caused by hydroxyurea: report of 9 cases.
    Aste N; Fumo G; Contu F; Aste N; Biggio P
    J Am Acad Dermatol; 2002 Jul; 47(1):146-7. PubMed ID: 12077597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transverse melanonychia.
    Mirfazaelian H; Alaeen A; Daneshbod Y
    Br J Hosp Med (Lond); 2014 Jul; 75(7):413. PubMed ID: 25040526
    [No Abstract]   [Full Text] [Related]  

  • 26. [Yellow-nail syndrome from d-penicillamine].
    Lubach D; Marghescu S
    Hautarzt; 1979 Oct; 30(10):547-9. PubMed ID: 521278
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toxicity and side effects of hydroxyurea used for primary thrombocythemia.
    Randi ML; Ruzzon E; Tezza F; Luzzatto G; Fabris F
    Platelets; 2005; 16(3-4):181-4. PubMed ID: 16011962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transverse melanonychia in a child receiving chemotherapy.
    Stephens M; Rubin AI; Castelo-Soccio L
    Pediatr Dermatol; 2019 Jan; 36(1):e60-e61. PubMed ID: 30548576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zidovudine-induced nail pigmentation.
    Azon-Masoliver A; Mallolas J; Gatell J; Castel T
    Arch Dermatol; 1988 Oct; 124(10):1570-1. PubMed ID: 3262330
    [No Abstract]   [Full Text] [Related]  

  • 30. Nail changes after chemotherapy.
    Las Heras G; Juncà Piera J
    Haematologica; 1998 Aug; 83(8):748. PubMed ID: 9793260
    [No Abstract]   [Full Text] [Related]  

  • 31. Yellow nail pigmentation due to methotrexate.
    Malka N; Reichert S; Trechot P; Barbaud A; Schmutz JL
    Dermatology; 1998; 197(3):276. PubMed ID: 9867364
    [No Abstract]   [Full Text] [Related]  

  • 32. Cyclophosphamide nail pigmentation.
    Adam BA
    Singapore Med J; 1981 Feb; 22(1):35-7. PubMed ID: 7017940
    [No Abstract]   [Full Text] [Related]  

  • 33. [What should follow a treatment for pruritus in thrombocytosis?].
    Wollina U
    Dtsch Med Wochenschr; 2003 Mar; 128(12):631. PubMed ID: 12649803
    [No Abstract]   [Full Text] [Related]  

  • 34. Skin changes secondary to hydroxyurea therapy.
    Kennedy BJ; Smith LR; Goltz RW
    Arch Dermatol; 1975 Feb; 111(2):183-7. PubMed ID: 1054261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Nail pigmentation caused by antimalarials].
    Pigrau C; Buti M; Janesca J; González A
    Med Clin (Barc); 1983 Apr; 80(11):512. PubMed ID: 6865530
    [No Abstract]   [Full Text] [Related]  

  • 36. Longitudinal melanonychia induced by minocycline.
    Mallon E; Dawber RP
    Br J Dermatol; 1994 Jun; 130(6):794-5. PubMed ID: 8011510
    [No Abstract]   [Full Text] [Related]  

  • 37. Transverse melanonychia and palmar hyperpigmentation secondary to hydroxyurea therapy.
    Schoenfeld J; Tulbert BH; Cusack CA
    Cutis; 2017 May; 99(5):E2-E4. PubMed ID: 28632807
    [No Abstract]   [Full Text] [Related]  

  • 38. Azidothymidine-induced hyperpigmentation of skin and nails.
    Bendick C; Rasokat H; Steigleder GK
    Arch Dermatol; 1989 Sep; 125(9):1285-6. PubMed ID: 2774609
    [No Abstract]   [Full Text] [Related]  

  • 39. Melanonychia induced by topical 5-fluorouracil.
    Baran R; Laugier P
    Br J Dermatol; 1985 May; 112(5):621-5. PubMed ID: 4005160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mucocutaneous lesions and nail pigmentation in a patient with essential thrombocytosis.
    Calleja Algarra A; Miguel RA; Tous Romero F; Maroñas Jiménez L
    Aust Fam Physician; 2017; 46(4):222-224. PubMed ID: 28376576
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.